Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Psychiatry|September 18, 2009
Assessing onset of treatment benefit in depression and anxiety: conceptual considerationsEugene M Laska, Craig H Mallinckrodt, Jim C Mundt, et al.
Expert Review of Neurotherapeutics|July 6, 2007
Cardiovascular effects of antipsychoticsJames W Michelsen, Jonathan M Meyer
Schizophrenia Research|July 13, 2004
The effects of antipsychotic therapy on serum lipids: a comprehensive reviewJonathan M Meyer, Carol E Koro
CNS Drugs|July 20, 2023
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in SchizophreniaJonathan M Meyer, Christoph U Correll
Essential Psychopharmacology|May 5, 2005
Atypical antipsychotic therapy and hyperlipidemia: a reviewCarol E Koro, Jonathan M Meyer
Focus (American Psychiatric Publishing)|January 30, 2026
Xanomeline-Trospium for the Treatment of SchizophreniaMegan J Ehret, Jonathan M Meyer
The American Journal of Psychiatry|June 17, 2011
Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled studyHerbert Y Meltzer, Josephine Cucchiaro, Robert Silva, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 10, 2009
Increased use of antibiotics in patients treated with clozapineJimmi Nielsen, Leslie Foldager, Jonathan M Meyer
The American Journal of Psychiatry|May 5, 2009
Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophreniaCarla M Canuso, Bryan Dirks, Jennifer Carothers, et al.
Schizophrenia Research|February 23, 2010
Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patientsMargaret K Vernon, Dennis A Revicki, A George Awad, et al.
Pageof 14